Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Acta Biomater. 2018 Aug 18;79:253–264. doi: 10.1016/j.actbio.2018.08.016

Table 3.

Graft-specific antibody production towards ASB-16 3% was not significantly different from GFBP.

Scaffold D0 D7 D14 D28 D42 D56
Native 1±0 2.8 ± 2.0 47.3 ± 22.3 191.6 ± 101.8 42.5 ± 18.3 135.7 ± 94.9 a
GFBP 1±0 1.3±0.5 1.7 ± 0.5 21.4±15.5 10.8±8.5 14.5 ± 7.3 b
ASB-14 5% 1±0 1.4±0.5 66.5 ± 57.0 286.1 ± 82.0 72.3 ±25.5 50.9 ± 26.2 a
ASB-16 3% 1±0 0.83 ± 0.06 48.2 ± 34.7 93.5 ± 17.6 85.4 ± 55.4 71.7 ±56.6 ab
c’ c’ b’ a’ b’ b’